Australian Survey Reveals Biosimilar Awareness, Switching Concerns
This article was originally published in The Pink Sheet Daily
Patients were less concerned about being prescribed a biosimilar if it was a new prescription or "if efficacy on the reference brand had waned." Medical professionals' concerns related to effectiveness, impact on patient outcomes, and switching.
Register for our free email digests: